Literature DB >> 10859487

Testosterone suppresses the response of the hypothalamic-pituitary-adrenal axis to interleukin-6.

A D Papadopoulos1, S L Wardlaw.   

Abstract

OBJECTIVES: Endotoxin and the inflammatory cytokines interleukin (IL)-1 and IL-6 are potent activators of the hypothalamic-pituitary-adrenal (HPA) axis. Previous studies in the rodent and in the primate have shown that the responses of the HPA axis to endotoxin and to IL-1 were enhanced by gonadectomy and attenuated by testosterone or estradiol replacement. The mechanisms underlying these observations are unclear, but there is evidence that gonadal steroids have direct inhibitory effects on IL-6 synthesis and release. Since endotoxin and IL-1 both stimulate IL-6, the question arises as to whether the sex-steroid-induced suppression of the HPA response to endotoxin and IL-1 results solely from decreased IL-6 release, or whether other mediators are involved.
METHODS: We have therefore examined the ACTH and corticosterone responses to IL-6 in intact and castrated male rats with and without testosterone replacement. Animals were castrated 2 weeks prior to study; testosterone was replaced by subcutaneous Silastic capsules. Four days prior to study, an indwelling right atrial catheter was implanted. Blood samples for ACTH and corticosterone radioimmunoassays were collected through the catheter 0, 20, 40, 60, 120 and 180 min after intravenous injection of recombinant human IL-6 (500 ng).
RESULTS: IL-6 stimulated ACTH and corticosterone release in all groups, with peak stimulation occurring within the first hour. The release of both ACTH and corticosterone was significantly attenuated in the intact (n = 9) and testosterone-replaced (n = 5) animals compared to the castrated animals without replacement (n = 7). Peak ACTH levels were 340 +/- 58 and 133 +/- 41 pg/ml in the intact and testosterone-replaced animals versus 678 +/- 170 pg/ml in the castrated animals (p < 0.02). Peak corticosterone levels were 29 +/- 4.7 and 30 +/- 4.2 microg/dl in the intact and testosterone-replaced animals versus 47 +/- 5.8 microg/dl in the castrated animals (p < 0.05).
CONCLUSIONS: We conclude that testosterone attenuates the response of the HPA axis to IL-6 in the rat. This would indicate that other mechanisms, in addition to the inhibition of IL-6 release, are responsible for restraining the HPA response to inflammatory stimuli in the presence of gonadal steroids. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859487     DOI: 10.1159/000026451

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  10 in total

1.  Effects of testosterone administration on nocturnal cortisol secretion in healthy older men.

Authors:  Ranganath Muniyappa; Johannes D Veldhuis; S Mitchell Harman; John D Sorkin; Marc R Blackman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-07-30       Impact factor: 6.053

2.  Testosterone suppression of CRH-stimulated cortisol in men.

Authors:  David R Rubinow; Catherine A Roca; Peter J Schmidt; Merry A Danaceau; Karen Putnam; Giovanni Cizza; George Chrousos; Lynnette Nieman
Journal:  Neuropsychopharmacology       Date:  2005-10       Impact factor: 7.853

3.  Increased testosterone-to-cortisol ratio in psychopathy.

Authors:  Andrea L Glenn; Adrian Raine; Robert A Schug; Yu Gao; Douglas A Granger
Journal:  J Abnorm Psychol       Date:  2011-05

4.  Testosterone and immune-reproductive tradeoffs in healthy women.

Authors:  Tierney K Lorenz; Julia R Heiman; Gregory E Demas
Journal:  Horm Behav       Date:  2016-11-17       Impact factor: 3.587

Review 5.  Testosterone deficiency, insulin resistance and the metabolic syndrome.

Authors:  Michael Zitzmann
Journal:  Nat Rev Endocrinol       Date:  2009-10-27       Impact factor: 43.330

6.  Proinflammatory Cytokine Infusion Attenuates LH's Feedforward on Testosterone Secretion: Modulation by Age.

Authors:  Johannes Veldhuis; Rebecca Yang; Ferdinand Roelfsema; Paul Takahashi
Journal:  J Clin Endocrinol Metab       Date:  2015-11-24       Impact factor: 5.958

7.  Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.

Authors:  Ken Tawara; Julia T Oxford; Cheryl L Jorcyk
Journal:  Cancer Manag Res       Date:  2011-05-18       Impact factor: 3.989

8.  Adrenal Function in females with low plasma HDL-C due to mutations in ABCA1 and LCAT.

Authors:  Andrea E Bochem; Adriaan G Holleboom; Johannes A Romijn; Menno Hoekstra; Geesje M Dallinga; Mahdi M Motazacker; G Kees Hovingh; Jan A Kuivenhoven; Erik S G Stroes
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

Review 9.  Cytokines in Endocrine Dysfunction of Plasma Cell Disorders.

Authors:  Eva Feigerlová; Shyue-Fang Battaglia-Hsu
Journal:  Mediators Inflamm       Date:  2017-06-27       Impact factor: 4.711

Review 10.  Fibromyalgia: symptom constellation and potential therapeutic options.

Authors:  Marjorie L Shuer
Journal:  Endocrine       Date:  2003-10       Impact factor: 3.925

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.